{"id":852698,"date":"2025-05-20T08:04:44","date_gmt":"2025-05-20T12:04:44","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\/"},"modified":"2025-05-20T08:04:44","modified_gmt":"2025-05-20T12:04:44","slug":"trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\/","title":{"rendered":"TriLink BioTechnologies\u00ae debuts its first mRNA synthesis kit with CleanCap\u00ae capping technology; Celebrates launch with kit donations to top academic institutions"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>TriLink BioTechnologies\u00ae debuts its first mRNA synthesis kit with CleanCap\u00ae capping technology; Celebrates launch with kit donations to top academic institutions<\/b><\/p>\n<p class=\"bwalignc\"><i>New all-in-one IVT kit can deliver up to 2X more mRNA and up to 85% lower dsRNA compared to other kits on the market through streamlined mRNA synthesis with efficient capping, increased yield, reduced dsRNA, and enhanced performance<\/i><\/p>\n<p>SAN DIEGO&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.trilinkbiotech.com%2F&amp;esheet=54257039&amp;newsitemid=20250520267814&amp;lan=en-US&amp;anchor=TriLink+BioTechnologies&amp;index=1&amp;md5=d0e424440efc37a9e9b38a277158eddb\">TriLink BioTechnologies<\/a>\u00ae (TriLink\u00ae), a Maravai\u00ae LifeSciences company (NASDAQ: MRVI), is fueling the future of mRNA research \u2014 starting with a significant donation to top academic labs across the U.S. and Europe.\n<\/p>\n<p>\nThe donation commemorates the launch of TriLink\u2019s first <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftrilinkbiotech.com%2Fcleancap-ivt-kits&amp;esheet=54257039&amp;newsitemid=20250520267814&amp;lan=en-US&amp;anchor=mRNA+synthesis+kit&amp;index=2&amp;md5=10cb95d3eb0cfb8f9c96258074fbfeac\">mRNA synthesis kit<\/a> featuring CleanCap\u00ae capping technology, an all-in-one kit with its innovative products in one box at a competitive price. Seven academic institutions will receive ten kits each that can yield up to a combined 250mg of capped mRNAs, enabling and encouraging further discovery and development in the field of mRNA-based medicine.\n<\/p>\n<p>\nLabs in academic institutions, such as those listed below, have gratefully accepted the kits donated by TriLink to drive progress in RNA therapeutics and build a strong future for the field.\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nThe Center for RNA Therapeutics at Houston Methodist Research Institute (HMRI)\n<\/li>\n<li>\nThe Center of RNA Technologies and Therapeutics at UC San Diego\n<\/li>\n<li>\nThe University Medical Center Utrecht\n<\/li>\n<li>\nThe University of Oxford\n<\/li>\n<li>\nYale School of Medicine\n<\/li>\n<\/ul>\n<p>\nThe new <i>in vitro<\/i> transcription (IVT) kit will simplify mRNA synthesis and elevate IVT by leveraging TriLink\u2019s high-performing products where users can expect up to 2X more mRNA yield and up to 85% lower dsRNA compared to other kits on the market. The IVT kit components include:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.trilinkbiotech.com%2Fcleancap-reagent-ag-3-ome.html&amp;esheet=54257039&amp;newsitemid=20250520267814&amp;lan=en-US&amp;anchor=CleanCap%26%23174%3B+AG+%283%26%238242%3B+OMe%29&amp;index=3&amp;md5=b347179ae00eb2c566bb7ffc698a0def\">CleanCap\u00ae AG (3\u2032 OMe)<\/a> for co-transcriptional capping\n<\/li>\n<li><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.trilinkbiotech.com%2Fcleanscribe-rna-polymerase.html&amp;esheet=54257039&amp;newsitemid=20250520267814&amp;lan=en-US&amp;anchor=CleanScribe%26%238482%3B+RNA+Polymerase&amp;index=4&amp;md5=10f50085c672dd825897927874d4807c\">CleanScribe\u2122 RNA Polymerase<\/a> for dsRNA reduction\n<\/li>\n<li><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.trilinkbiotech.com%2Fbrowse%2Fnucleoside-triphosphates-nucleotides&amp;esheet=54257039&amp;newsitemid=20250520267814&amp;lan=en-US&amp;anchor=Nucleotides+including+N1-methylpseuouridine&amp;index=5&amp;md5=6d9fb4fe33940c3648a6d1443b2a762a\">Nucleotides including N1-methylpseuouridine<\/a> for enhanced mRNA performance, and\n<\/li>\n<li><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fgo.trilinkbiotech.com%2Fcleanscript-technote&amp;esheet=54257039&amp;newsitemid=20250520267814&amp;lan=en-US&amp;anchor=CleanScript%26%23174%3B+IVT&amp;index=6&amp;md5=4f9c217670825905028a1a55813f06d4\">CleanScript\u00ae IVT<\/a> for increased yield.\n<\/li>\n<\/ul>\n<p>\n\u201cThis launch brings together a powerful suite of novel IVT components that reflect TriLink\u2019s years of experience and innovation in mRNA synthesis,\u201d shared Justin Barbosa, Vice President &amp; General Manager of TriLink Discovery. \u201cBy offering all these components in a single kit, we\u2019re simplifying researcher workflow and accelerating discovery. The addition of CleanScript IVT optimization also ensures our customers can generate more high-quality mRNA per reaction \u2014 maximizing both efficiency and performance.\u201d\n<\/p>\n<p>\nThe kit comes ready to use and is the only commercially available IVT kit featuring CleanCap AG (3\u2032 OMe), which is a modified version of the original CleanCap AG with over 95% capping efficiency to improve protein expression. CleanCap co-transcriptional capping provides advantages over legacy capping methods of ARCA or enzymatic by streamlining mRNA manufacturing with fewer steps and handling, thereby saving researchers time and resources.\n<\/p>\n<p>\n\u201cThis is an important product launch, where we are bringing several technology and process improvements to an integrated IVT kit,\u201d said Trey Martin, CEO of Maravai. \u201cToday we are also making a statement about our commitment to the future of mRNA science. By donating the first new kits to top academic institutions across the U.S. and Europe, we are investing in the next generation of mRNA innovators and empowering groundbreaking research that could lead to the therapies of tomorrow. We are honored to help our field continue to evolve and improve through new innovations and process improvements.\u201d\n<\/p>\n<p>\nWith more than 25 years of experience in nucleic acid product development and manufacturing, TriLink is a recognized leader in advancing mRNA and oligo-based therapeutic innovation. Its CleanCap AG (3\u2032 OMe) cap analog is <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41586-020-2814-7&amp;esheet=54257039&amp;newsitemid=20250520267814&amp;lan=en-US&amp;anchor=used+in+commercially+approved+vaccines&amp;index=7&amp;md5=981cab8ffa3087772c359ad61b43d010\">used in commercially approved vaccines<\/a>, of which billion of doses have been administered worldwide with a tremendous safety profile. TriLink\u2019s reagents and services are available for research use only (RUO) and for GMP manufacturing, supporting applications from discovery to commercialization in the genomic space.\n<\/p>\n<p>\nIf you are interested in research &amp; development collaboration, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.maravai.com%2Fcollaborate%2F&amp;esheet=54257039&amp;newsitemid=20250520267814&amp;lan=en-US&amp;anchor=maravai.com%2Fcollaborate.&amp;index=8&amp;md5=864715346abdefc82d4eb4cdedcdfa48\">maravai.com\/collaborate.<\/a> To learn more about TriLink\u2019s products and services, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.trilinkbiotech.com%2F&amp;esheet=54257039&amp;newsitemid=20250520267814&amp;lan=en-US&amp;anchor=trilinkbiotech.com&amp;index=9&amp;md5=d431ef450dac81057664f11280de7340\">trilinkbiotech.com<\/a>.\n<\/p>\n<p><b>About TriLink BioTechnologies<\/b><\/p>\n<p>\nTriLink BioTechnologies, a Maravai LifeSciences company, is a global leader in nucleic acid and mRNA solutions. TriLink delivers unrivaled chemical and biological experience, CDMO services, and high-quality readymade and custom materials, including its patented CleanCap\u00ae mRNA capping technology. Pharmaceutical leaders, biotech disruptors, and world governments depend on TriLink to meet their greatest challenges, from delivering the COVID-19 vaccine at warp speed, to empowering innovative treatments in oncology, infectious diseases, cardiology, and neurological disorders, to enabling future pandemic response plans. For more information about TriLink, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.trilinkbiotech.com%2F&amp;esheet=54257039&amp;newsitemid=20250520267814&amp;lan=en-US&amp;anchor=trilinkbiotech.com&amp;index=10&amp;md5=608a78fe2b679bf6a96025197ed35c46\">trilinkbiotech.com<\/a>.\n<\/p>\n<p><b>About Maravai LifeSciences<\/b><\/p>\n<p>\nMaravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics and novel vaccines. Maravai\u2019s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world&#8217;s leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.\n<\/p>\n<p>\nFor more information about Maravai LifeSciences, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3DDs8e7p_PfdqCJM8Kz1p8UVtwZkuSRcO3ikqBgEjOMC1k2BB_lAQeW49orS59OnXs-qFXySxoBWO66OQiQAr5ZU3iKHq6uUs3mW_80PwzXHpVnvD3KtKZr5Axyg8BmQs9hjJIR5-S4b4QNDdR_A0taFjXo5Ny5BfFMj1UowX11r0LVXOo0k2DZJJqUNYf5Sj1FgAp2yikzX53PAYaeq6MFpKXgp5vXGs5gZpWP2ALYJU%3D&amp;esheet=54257039&amp;newsitemid=20250520267814&amp;lan=en-US&amp;anchor=www.maravai.com&amp;index=11&amp;md5=9c6adb56040dc9ae6a203e7e2fd10bf2\">www.maravai.com<\/a>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250520267814r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20250520267814\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250520267814\/en\/<\/a><\/span><\/p>\n<p>\nInvestor Contact:<br \/>\n<br \/>Deb Hart<br \/>\n<br \/>Maravai LifeSciences<br \/>\n<br \/>858-988-5917<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:ir@maravai.com\">ir@maravai.com<\/a><\/p>\n<p>\nMedia Contact:<br \/>\n<br \/>Liz Robinson of CG Life<br \/>\n<br \/>TriLink BioTechnologies<br \/>\n<br \/>312-997-2436<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:lrobinson@cglife.com\">lrobinson@cglife.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America California<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Science Other Science Biotechnology Research Health FDA Infectious Diseases Genetics<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250520267814\/en\/2473934\/3\/TriLink_Logo_300x300_20221207.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>TriLink BioTechnologies\u00ae debuts its first mRNA synthesis kit with CleanCap\u00ae capping technology; Celebrates launch with kit donations to top academic institutions New all-in-one IVT kit can deliver up to 2X more mRNA and up to 85% lower dsRNA compared to other kits on the market through streamlined mRNA synthesis with efficient capping, increased yield, reduced dsRNA, and enhanced performance SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;TriLink BioTechnologies\u00ae (TriLink\u00ae), a Maravai\u00ae LifeSciences company (NASDAQ: MRVI), is fueling the future of mRNA research \u2014 starting with a significant donation to top academic labs across the U.S. and Europe. The donation commemorates the launch of TriLink\u2019s first mRNA synthesis kit featuring CleanCap\u00ae capping technology, an all-in-one kit with its innovative products in one box at a competitive &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;TriLink BioTechnologies\u00ae debuts its first mRNA synthesis kit with CleanCap\u00ae capping technology; Celebrates launch with kit donations to top academic institutions&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-852698","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>TriLink BioTechnologies\u00ae debuts its first mRNA synthesis kit with CleanCap\u00ae capping technology; Celebrates launch with kit donations to top academic institutions - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TriLink BioTechnologies\u00ae debuts its first mRNA synthesis kit with CleanCap\u00ae capping technology; Celebrates launch with kit donations to top academic institutions - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"TriLink BioTechnologies\u00ae debuts its first mRNA synthesis kit with CleanCap\u00ae capping technology; Celebrates launch with kit donations to top academic institutions New all-in-one IVT kit can deliver up to 2X more mRNA and up to 85% lower dsRNA compared to other kits on the market through streamlined mRNA synthesis with efficient capping, increased yield, reduced dsRNA, and enhanced performance SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;TriLink BioTechnologies\u00ae (TriLink\u00ae), a Maravai\u00ae LifeSciences company (NASDAQ: MRVI), is fueling the future of mRNA research \u2014 starting with a significant donation to top academic labs across the U.S. and Europe. The donation commemorates the launch of TriLink\u2019s first mRNA synthesis kit featuring CleanCap\u00ae capping technology, an all-in-one kit with its innovative products in one box at a competitive &hellip; Continue reading &quot;TriLink BioTechnologies\u00ae debuts its first mRNA synthesis kit with CleanCap\u00ae capping technology; Celebrates launch with kit donations to top academic institutions&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-20T12:04:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250520267814r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"TriLink BioTechnologies\u00ae debuts its first mRNA synthesis kit with CleanCap\u00ae capping technology; Celebrates launch with kit donations to top academic institutions\",\"datePublished\":\"2025-05-20T12:04:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\\\/\"},\"wordCount\":870,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250520267814r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\\\/\",\"name\":\"TriLink BioTechnologies\u00ae debuts its first mRNA synthesis kit with CleanCap\u00ae capping technology; Celebrates launch with kit donations to top academic institutions - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250520267814r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2025-05-20T12:04:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250520267814r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250520267814r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TriLink BioTechnologies\u00ae debuts its first mRNA synthesis kit with CleanCap\u00ae capping technology; Celebrates launch with kit donations to top academic institutions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TriLink BioTechnologies\u00ae debuts its first mRNA synthesis kit with CleanCap\u00ae capping technology; Celebrates launch with kit donations to top academic institutions - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\/","og_locale":"en_US","og_type":"article","og_title":"TriLink BioTechnologies\u00ae debuts its first mRNA synthesis kit with CleanCap\u00ae capping technology; Celebrates launch with kit donations to top academic institutions - Market Newsdesk","og_description":"TriLink BioTechnologies\u00ae debuts its first mRNA synthesis kit with CleanCap\u00ae capping technology; Celebrates launch with kit donations to top academic institutions New all-in-one IVT kit can deliver up to 2X more mRNA and up to 85% lower dsRNA compared to other kits on the market through streamlined mRNA synthesis with efficient capping, increased yield, reduced dsRNA, and enhanced performance SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;TriLink BioTechnologies\u00ae (TriLink\u00ae), a Maravai\u00ae LifeSciences company (NASDAQ: MRVI), is fueling the future of mRNA research \u2014 starting with a significant donation to top academic labs across the U.S. and Europe. The donation commemorates the launch of TriLink\u2019s first mRNA synthesis kit featuring CleanCap\u00ae capping technology, an all-in-one kit with its innovative products in one box at a competitive &hellip; Continue reading \"TriLink BioTechnologies\u00ae debuts its first mRNA synthesis kit with CleanCap\u00ae capping technology; Celebrates launch with kit donations to top academic institutions\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\/","og_site_name":"Market Newsdesk","article_published_time":"2025-05-20T12:04:44+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250520267814r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"TriLink BioTechnologies\u00ae debuts its first mRNA synthesis kit with CleanCap\u00ae capping technology; Celebrates launch with kit donations to top academic institutions","datePublished":"2025-05-20T12:04:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\/"},"wordCount":870,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250520267814r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\/","name":"TriLink BioTechnologies\u00ae debuts its first mRNA synthesis kit with CleanCap\u00ae capping technology; Celebrates launch with kit donations to top academic institutions - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250520267814r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2025-05-20T12:04:44+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250520267814r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250520267814r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"TriLink BioTechnologies\u00ae debuts its first mRNA synthesis kit with CleanCap\u00ae capping technology; Celebrates launch with kit donations to top academic institutions"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/852698","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=852698"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/852698\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=852698"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=852698"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=852698"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}